Empowering sites and investigators in decentralize clinical trials

Empowering sites and investigators in decentralize clinical trials

What are the benefits of the decentralized clinical trial (DCT) model? What are the barriers to sites and investigators participating in DCTs? What support measures are critical to DCT success?

What is the outlook for DCTs in the next 3–5 years and how can sites and investigators contribute to their evolution?

Listen to a lively discussion of these questions and more, as industry experts discuss DCT and hybrid clinical trial models. Listen to this latest podcast from Scrip, presented in partnership with ICON.

    Get your free copy now!

    Leave a Reply